High Risk Multiple Gestation Study
Development of Non-invasive Prenatal Diagnostic Test for Multiple Gestation Pregnancies Based on Fetal DNA Isolated From Maternal Blood
Sponsor: Long Island Jewish Medical Center
Listed as NCT02278874, this observational or N/A phase trial focuses on Sex Chromosome Abnormalities and Trisomy 13 and remains completed. Sponsored by Long Island Jewish Medical Center, it has been updated 14 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
▶ Show 9 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jul 2019 — Nov 2020 [monthly]
Completed
-
Jan 2019 — Jul 2019 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2018 — Jan 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Long Island Jewish Medical Center
- MOUNT SINAI HOSPITAL
- Montefiore Medical Center
- Natera, Inc.
- Tufts Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .